TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TMDX TransMedics Group, Inc.

Trading 08-05 12:30:52 EDT

74.74

-6.01

-7.44%

High76.00	Low68.00	Vol1.65M
Open72.34	D1 Closing80.75	Amplitude9.91%
Mkt Cap2.58B	Tradable Cap2.49B	Total Shares34.54M
T/O119.90M	T/O Rate4.95%	Tradable Shares33.28M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TMDX","market":"US","secType":"STK","nameCN":"TransMedics Group, Inc.","latestPrice":74.74,"timestamp":1785947448037,"preClose":80.75,"halted":0,"volume":1648119,"delay":0,"changeRate":-0.0744272445820434,"floatShares":33275683,"shares":34544158,"eps":4.465339,"marketStatus":"Trading","change":-6.01,"latestTime":"08-05 12:30:52 EDT","open":72.335,"high":76,"low":68,"amount":119895854.63123399,"amplitude":0.099071,"askPrice":74.89,"askSize":102,"bidPrice":74.59,"bidSize":1,"shortable":0,"etf":0,"ttmEps":4.465339,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1785960000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1556769600000,"exchange":"NASDAQ","adjPreClose":80.75,"preHourTrading":{"tag":"盘前","latestPrice":71.96,"preClose":80.75,"latestTime":"09:29 EDT","volume":46584,"amount":3415193.2267199997,"timestamp":1785936599999,"change":-8.79,"changeRate":-0.108854,"amplitude":0.061176},"postHourTrading":{"tag":"盘后","latestPrice":74.424,"preClose":80.75,"latestTime":"19:58 EDT","volume":346656,"amount":28741535.5717,"timestamp":1785887909251,"change":-6.326,"changeRate":-0.078341,"amplitude":0.198142},"volumeRatio":3.062378,"impliedVol":0.6571,"impliedVolPercentile":0.5179},"requestUrl":"/m/hq/s/TMDX","defaultTab":"news","newsList":[{"id":"2657267805","title":"TransMedics Group Price Target Cut to $100.00/Share from $120.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2657267805","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657267805?lang=en_us&edition=fundamental","pubTime":"2026-08-06 00:12","pubTimestamp":1785946320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMDX/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU2065731478.USD","TMDX","BK4588","BK4082","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657470115","title":"UBS Adjusts Price Target on TransMedics Group to $77 From $80, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2657470115","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657470115?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:15","pubTimestamp":1785935751,"startTime":"0","endTime":"0","summary":"TransMedics Group (TMDX) has an average rating of overweight and mean price target of $97.30, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","TMDX","LU2065731478.USD","LU2324357040.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657054939","title":"TransMedics price target lowered to $95 from $124 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2657054939","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657054939?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:20","pubTimestamp":1785928852,"startTime":"0","endTime":"0","summary":"Canaccord lowered the firm’s price target on TransMedics (TMDX) to $95 from $124 and keeps a Buy rating on the shares. The firm said they reported ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transmedics-price-target-lowered-to-95-from-124-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transmedics-price-target-lowered-to-95-from-124-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMDX","BK4082","LU2324357040.USD","BK4588","BK4585","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657590939","title":"Transmedics Group, Inc. : Canaccord Genuity Cuts Target Price to $95 from $124","url":"https://stock-news.laohu8.com/highlight/detail?id=2657590939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657590939?lang=en_us&edition=fundamental","pubTime":"2026-08-05 13:33","pubTimestamp":1785908001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN4420LC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU2324357040.USD","BK4082","BK4585","TMDX","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657598278","title":"Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA) and TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657598278","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657598278?lang=en_us&edition=fundamental","pubTime":"2026-08-05 07:00","pubTimestamp":1785884418,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on IDEAYA Biosciences (IDYA) and TransMedics Group (TMD...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ideaya-biosciences-idya-and-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ideaya-biosciences-idya-and-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","IDYA","LU0029874061.USD","TMDX","BK4581","BK4082","XBI","HCSG","LU0128526141.USD","BK4137","BK4139","LU2324357040.USD","BK4588","LABU","BK4585","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657560390","title":"Transmedics Group Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657560390","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657560390?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:37","pubTimestamp":1785879471,"startTime":"0","endTime":"0","summary":"Transmedics Group Inc reports results for the quarter ended June 30 - Earnings SummaryTransmedics Group IncTMDX.OQreported quarterly adjusted earnings of 44 cents per share for the quarter ended June ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N44139C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","BK4588","TMDX","BK4585","LU2324357040.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657562612","title":"TransMedics Q2 Net Income Declines on R&D and Infrastructure Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2657562612","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657562612?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:44","pubTimestamp":1785876276,"startTime":"0","endTime":"0","summary":"TransMedics Q2 net income declines on R&D and infrastructure expensesOverviewUS organ transplant tech firm's Q2 revenue rose 21%, beating analyst expectationsAdjusted EPS for Q2 was $0.44; no analyst ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL1N441174:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4136","BK4198","BK4082","BK4196","AHCO","BK4585","UFPT","LU2324357040.USD","TMDX","VMD","BK4588","BK4175","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657643055","title":"TransMedics Q2 FY26 GAAP Net Income Drops 58% to USD 14.7 Million; Revenue Rises 21% to USD 189.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657643055","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657643055?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:26","pubTimestamp":1785875213,"startTime":"0","endTime":"0","summary":"TransMedics Q2 FY26 GAAP net income drops 58% to USD 14.7 million; revenue rises 21% to USD 189.9 millionTransMedics posted Q2 2026 revenue of USD 189.9 million, up 21% from a year earlier.GAAP net in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL9rXrbV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","TMDX","BK4585","BK4082","BK4588","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657356920","title":"TransMedics Gr Q2 Adj. EPS $0.44 Misses $0.47 Estimate, Sales $189.948M Beat $183.635M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657356920","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657356920?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:08","pubTimestamp":1785874130,"startTime":"0","endTime":"0","summary":"TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.44 per share which missed the analyst consensus estimate of $0.47 by 6.38 percent. This is a 52.17 percent decrease over earnings of $0.92 per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60929003/transmedics-gr-q2-adj-eps-0-44-misses-0-47-estimate-sales-189-948m-beat-183-635m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TransMedics Gr Q2 Adj. EPS $0.44 Misses $0.47 Estimate, Sales $189.948M Beat $183.635M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2324357040.USD","LU2065731478.USD","BK4585","BK4082","TMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657692825","title":"Transmedics Group Q2 EPS USD 0.41","url":"https://stock-news.laohu8.com/highlight/detail?id=2657692825","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657692825?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:06","pubTimestamp":1785873963,"startTime":"0","endTime":"0","summary":"BRIEF-Transmedics Group Q2 EPS USD 0.41Aug 04 (Reuters) - Transmedics Group Q2 gross margin 60%.Q2 net income USD 14.7 millionQ2 revenue USD 189.9 million vs. IBES estimate USD 183.6 millionoutlook FY revenue USD 737-757 million vs. IBES estimate USD 732.7 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nPLXMRQ026:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMDX","LU2324357040.USD","LU2065731478.USD","BK4588","BK4082","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657564898","title":"Transmedics Group Inc Fy2026 REV View $732.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2657564898","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657564898?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:05","pubTimestamp":1785873905,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nPLXMRQ026:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU2324357040.USD","LU2065731478.USD","BK4585","BK4082","TMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656016503","title":"TransMedics Grants 9 New Hires Stock Options for 18,762 Shares at $78, Awards 12,414 RSUs","url":"https://stock-news.laohu8.com/highlight/detail?id=2656016503","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656016503?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:08","pubTimestamp":1785787720,"startTime":"0","endTime":"0","summary":"TransMedics grants 9 new hires stock options for 18,762 shares at $78, awards 12,414 RSUsTransMedics granted inducement equity awards on July 29, 2026 to 9 new employees under its Inducement Plan.Awar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDLcbRhhH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4585","LU2065731478.USD","TMDX","LU2324357040.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656013513","title":"Transmedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656013513","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656013513?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:05","pubTimestamp":1785787503,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUA1YWYFM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","LU2065731478.USD","TMDX","LU2324357040.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655813411","title":"TransMedics Group Lawsuit Ruling: Court Allows Key Investor Claims Over Alleged Forced Bundling to Move Forward","url":"https://stock-news.laohu8.com/highlight/detail?id=2655813411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655813411?lang=en_us&edition=fundamental","pubTime":"2026-07-30 03:19","pubTimestamp":1785352753,"startTime":"0","endTime":"0","summary":"A federal judge in Massachusetts has allowed part of a securities lawsuit against TransMedics Group (TMDX) to proceed, while dismissing several oth...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/transmedics-group-lawsuit-ruling-court-allows-key-investor-claims-over-alleged-forced-bundling-to-move-forward?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/transmedics-group-lawsuit-ruling-court-allows-key-investor-claims-over-alleged-forced-bundling-to-move-forward?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065731478.USD","BK4082","BK4588","TMDX","LU2324357040.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137881948","title":"Earning Preview: TransMedics Group, Inc. Q2 revenue is expected to increase by 24.01%, institutional views tilt bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1137881948","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137881948?lang=en_us&edition=fundamental","pubTime":"2026-07-29 11:24","pubTimestamp":1785295447,"startTime":"0","endTime":"0","summary":"Abstract TransMedics Group, Inc. will report fiscal second-quarter 2026 results on August 04, 2026 Post Market, and this preview consolidates the latest quarterly forecasts, last quarter’s actuals,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: TransMedics Group, Inc. Q2 revenue is expected to increase by 24.01%, institutional views tilt bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655356882","title":"TransMedics Group Initiated at Neutral by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2655356882","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655356882?lang=en_us&edition=fundamental","pubTime":"2026-07-29 02:58","pubTimestamp":1785265080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMDX/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","TMDX","BK4585","LU2324357040.USD","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654005077","title":"UBS Initiates TransMedics Group at Neutral With $80 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2654005077","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654005077?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:56","pubTimestamp":1785236176,"startTime":"0","endTime":"0","summary":"TransMedics Group (TMDX) has an average rating of overweight and mean price target of $112.89, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","LU2065731478.USD","BK4588","BK4585","TMDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653788518","title":"Transmedics Schedules Second-quarter Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2653788518","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653788518?lang=en_us&edition=fundamental","pubTime":"2026-07-22 04:06","pubTimestamp":1784664366,"startTime":"0","endTime":"0","summary":"TransMedics schedules second-quarter results conference callTransMedics will release second-quarter 2026 financial results on Aug. 4, 2026.Management will host a conference call on Aug. 4, 2026 at 4:3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL8MS0Qf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4082","BK4585","LU2065731478.USD","LU2324357040.USD","TMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652420408","title":"TransMedics Group (TMDX) Stock Still Looks Below Fair Value After A 154% Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2652420408","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652420408?lang=en_us&edition=fundamental","pubTime":"2026-07-17 15:20","pubTimestamp":1784272849,"startTime":"0","endTime":"0","summary":"After a mixed few years for shareholders, TransMedics Group stock now sits at around US$76 with a 5 year return of roughly 154%, and the current valuation checks suggest that, despite recent share price pressure, the stock still leans toward the cheaper side of the spectrum.\n\nOver 5 years, TransMedics Group has returned about 153.6%, which puts the recent 1 year and year to date share price declines in the context of a much stronger longer term run.\nThe recent investment in Germany based PAD...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/transmedics-group-tmdx-stock-still-looks-below-fair-value-af","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/transmedics-group-tmdx-stock-still-looks-below-fair-value-af","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","LU2324357040.USD","TMDX","BK4588","LU2065731478.USD","BK4082","TSPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651143954","title":"Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651143954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651143954?lang=en_us&edition=fundamental","pubTime":"2026-07-14 00:10","pubTimestamp":1783959019,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Me...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alkermes-alks-transmedics-group-tmdx-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alkermes-alks-transmedics-group-tmdx-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","IE00B4R5TH58.HKD","LU0109394709.USD","LU2065731478.USD","BK4139","IE00BFTCPJ56.SGD","BK4581","LU2324357040.USD","LU0320765992.SGD","IE0009355771.USD","XBI","BK4082","IE0002141913.USD","LU0889565916.HKD","LABU","BK4588","TMDX","IBRN","ALKS","IE00BJJMRZ35.SGD","BK4585","IE00BJT1NW94.SGD","LU0128526141.USD","HCSG","XLV","MEDX","PSCH","IE00B2B36J28.USD","BK4137","PSIL","PRAX","FBT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transmedics.com","stockEarnings":[{"period":"1week","weight":0.0585},{"period":"1month","weight":0.1727},{"period":"3month","weight":0.1074},{"period":"6month","weight":-0.3769},{"period":"1year","weight":-0.3716},{"period":"ytd","weight":-0.3362}],"compareEarnings":[{"period":"1week","weight":0.0411},{"period":"1month","weight":0.0356},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.2221},{"period":"ytd","weight":0.1311}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.026649},{"month":2,"riseRate":0.714286,"avgChangeRate":0.153587},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.028866},{"month":4,"riseRate":0.714286,"avgChangeRate":0.095218},{"month":5,"riseRate":0.428571,"avgChangeRate":0.061567},{"month":6,"riseRate":0.875,"avgChangeRate":0.137203},{"month":7,"riseRate":0.5,"avgChangeRate":0.007949},{"month":8,"riseRate":0.625,"avgChangeRate":0.042289},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.096617},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.144574},{"month":11,"riseRate":0.857143,"avgChangeRate":0.223183},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.026786}],"exchange":"NASDAQ","name":"TransMedics Group, Inc.","nameEN":"TransMedics Group, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TransMedics Group, Inc.,TMDX,TransMedics Group, Inc.股票,TransMedics Group, Inc.股票老虎,TransMedics Group, Inc.股票老虎国际,TransMedics Group, Inc.行情,TransMedics Group, Inc.股票行情,TransMedics Group, Inc.股价,TransMedics Group, Inc.股市,TransMedics Group, Inc.股票价格,TransMedics Group, Inc.股票交易,TransMedics Group, Inc.股票购买,TransMedics Group, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}